These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 6114170)

  • 21. Dynorphin (1-13): analgesia, hypothermia, cross-tolerance with morphine and beta-endorphin.
    Petrie EC; Tiffany ST; Baker TB; Dahl JL
    Peptides; 1982; 3(1):41-7. PubMed ID: 6281745
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Alterations in brain dopamine and serotonin metabolism during the development of tolerance to human beta-endorphin in rats.
    Van Loon GR; De Souza EB; Kim C
    Can J Physiol Pharmacol; 1978 Dec; 56(6):1067-71. PubMed ID: 743624
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Tyr-MIF-1 attenuates development of tolerance to spiperone-induced catalepsy in rats.
    Kostrzewa RM; Kastin AJ
    Brain Res Bull; 1993; 31(6):707-12. PubMed ID: 8100182
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Intragastric administration of cyclo(Leu-Gly) inhibits the development of tolerance to the analgesic effect of morphine in the rat.
    Bhargava HN
    Life Sci; 1988; 43(2):187-92. PubMed ID: 3393061
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effect of peptides on the development of tolerance to buprenorphine, a mixed opiate agonist-antagonist analgesic.
    Bhargava HN
    Eur J Pharmacol; 1982 Apr; 79(1-2):117-23. PubMed ID: 7084303
    [TBL] [Abstract][Full Text] [Related]  

  • 26. beta-Endorphin-like immunoreactivity in discrete brain regions, spinal cord, pituitary gland and peripheral tissues of U-50,488H-tolerant and -abstinent rats.
    Bhargava HN; Matwyshyn GA; Rattan AK; Koo KL; Tejwani GA
    J Pharmacol Exp Ther; 1994 Feb; 268(2):856-61. PubMed ID: 8113998
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cardiovascular and respiratory effects of beta-endorphin in anesthetized and conscious rats.
    Sitsen JM; Van Ree JM; De Jong W
    J Cardiovasc Pharmacol; 1982; 4(6):883-8. PubMed ID: 6185778
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effect of a spirocyclic cyclodipeptide derivate of MIF on passive avoidance behavior and amnesia in rats.
    Krejcí I; Dlabac A; Vanzura J; Kosnar J
    Act Nerv Super (Praha); 1986 Dec; 28(4):241-6. PubMed ID: 2881422
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effect of H2 receptor blockade upon hypothermic, cataleptogenic and antinociceptive action of prostacyclin (PGI)2 administered into the lateral rat brain ventricle.
    Brus R; Krzemiński T; Juraszczyk Z; Kurocok A
    Biomed Biochim Acta; 1985; 44(4):637-44. PubMed ID: 2862862
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pro-Leu-Gly-NH2 and pareptide inhibit development of tolerance to haloperidol catalepsy in the mouse.
    Mycroft FJ; Wei ET
    Peptides; 1984; 5(5):883-7. PubMed ID: 6150468
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The effects of centrally acting peptides on the chronic actions of buprenorphine in the rat.
    Bhargava HN
    NIDA Res Monogr; 1982 Apr; 41():134-40. PubMed ID: 6126811
    [No Abstract]   [Full Text] [Related]  

  • 32. Inability of cyclo (LEU-GLY) to facilitate the development of tolerance to and physical dependence on morphine in the rat.
    Bhargava HN
    Life Sci; 1980 Sep; 27(12):1075-81. PubMed ID: 6106875
    [No Abstract]   [Full Text] [Related]  

  • 33. Neurotensin-induced antinociception in mice: antagonism by thyrotropin-releasing hormone.
    Osbahr AJ; Nemeroff CB; Luttinger D; Mason GA; Prange AJ
    J Pharmacol Exp Ther; 1981 Jun; 217(3):645-51. PubMed ID: 6112261
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Inhibition of tail-flick and shaking responses by intrathecal and intraventricular D-Ala2-D-Leu5-enkephalin and beta-endorphin in anesthetized rats.
    Tseng LF; Cheng SS; Fujimoto JM
    J Pharmacol Exp Ther; 1983 Jan; 224(1):51-4. PubMed ID: 6294283
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Development of tolerance to the ACTH-releasing effects of beta-endorphin.
    Van Loon GR; De Souza EB
    Res Commun Chem Pathol Pharmacol; 1978 Oct; 22(1):203-4. PubMed ID: 214831
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Long-term hyperalgesia induced by neonatal beta-endorphin and morphiceptin is blocked by neonatal Tyr-MIF-1.
    Zadina JE; Kastin AJ; Manasco PK; Pignatiello MF; Nastiuk KL
    Brain Res; 1987 Apr; 409(1):10-8. PubMed ID: 2884015
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The role of metabolism in the action of prolyl-leucyl-glycinamide on the development of tolerance to the analgesic effect of morphine.
    Bhargava HN
    Neuropharmacology; 1986 Jul; 25(7):737-41. PubMed ID: 2875417
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Potentiation of beta-endorphin effects by proglumide in rats.
    Katsuura G; Itoh S
    Eur J Pharmacol; 1985 Jan; 107(3):363-6. PubMed ID: 3156751
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Binding of [3H]spiroperidol to striatal membranes of rats treated chronically with morphine. Influence of Pro-Leu-Gly-NH2 and cyclo(Leu-Gly).
    Bhargava HN
    Neuropharmacology; 1983 Dec; 22(12A):1357-61. PubMed ID: 6141535
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Developmental, behavioral, and opiate receptor changes after prenatal or postnatal beta-endorphin, CRF, or Tyr-MIF-1.
    Zadina JE; Kastin AJ; Coy DH; Adinoff BA
    Psychoneuroendocrinology; 1985; 10(4):367-83. PubMed ID: 2868478
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.